- EcoVadis assessed over 150,000 companies globally.
- WuXi Biologics achieved ISO 20400 certification.
- The company supports 945 client projects, including 74 in Phase III and 25 in commercial manufacturing.
EcoVadis Platinum Recognition
WuXi Biologics has been awarded the EcoVadis Platinum Medal for the third consecutive year, placing it in the top 1% of over 150,000 companies evaluated globally. This recognition highlights the company's strong ESG performance across Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
Sustainability Initiatives
The company has implemented several initiatives to enhance its sustainability performance. WuXi Biologics' greenhouse gas emissions reduction targets have been approved by the Science Based Targets initiative (SBTi), making it one of the first in the industry to receive such approval. Additionally, the company has published a Green CRDMO White Paper, detailing its green innovation technologies and significant carbon reduction achievements.
Certifications and Standards
WuXi Biologics has achieved ISO 20400 Sustainable Procurement certification, which integrates sustainability principles into procurement practices. This certification promotes transparency and responsibility across the supply chain.
Global ESG Engagement
As a participant in the United Nations Global Compact and the Pharmaceutical Supply Chain Initiative, WuXi Biologics actively advocates for sustainability. The company has received multiple recognitions, including an MSCI AAA Rating, listing in the Dow Jones Sustainability Indices, and inclusion in the FTSE4Good Index Series. It has also been rated as a top ESG company by Sustainalytics and ISS ESG Corporate Rating.
